Blood Loss, Surgical Clinical Trial
Official title:
Misoprostol Effect on Second Trimester Abortion Blood Loss
Although serious complications from second trimester abortion are rare hemorrhage is the most common cause of procedural abortion related morbidity and mortality. Misoprostol is a prostaglandin E1 analogue that is used by 75% of clinicians prior to procedural abortion for the purpose of cervical preparation. Misoprostol is also known to decrease blood loss in first trimester abortion and is used to treat postpartum hemorrhage, however the effect of preprocedural misoprostol on procedural blood loss is not well described. We will conduct a double blinded placebo-controlled gestational age stratified superiority trial of those undergoing procedural abortion between 18 and 23 weeks gestation at Stanford Health care. Participants will be randomized to either 400mcg buccal misoprostol or placebo on the day of the procedure. A quantified blood loss (QBL) will be measured during the procedure and participants will complete a survey to assess symptoms. Our primary outcome is quantified blood loss. Secondary outcomes include clinical interventions to manage excess bleeding, total procedure time, provider reported experience, patient reported experience.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04114253 -
QStat in Liver Transplant
|
||
| Recruiting |
NCT05077124 -
Safe and Timely Antithrombotic Removal (STAR) Registry
|
||
| Active, not recruiting |
NCT03651154 -
Hypovolemic Phlebotomy to Reduce Blood Transfusions in Major Hepatic Resections
|
N/A | |
| Recruiting |
NCT04519593 -
ABSOLUTELY: A Temporary Uterine Blood Supply Occlusion for Laparoscopic Myomectomy in Patients With UTErine LeiomYoma
|
N/A | |
| Completed |
NCT02043132 -
Tranexamic Acid in Reverse Total Shoulder Arthroplasty
|
Phase 2/Phase 3 | |
| Withdrawn |
NCT00861367 -
Prospective Double-blind Study for the Use of Aspirin During Transurethral Surgery of the Bladder or the Prostate
|
N/A | |
| Terminated |
NCT03246919 -
Ideal Time of Oxytocin Infusion During Cesarean Section
|
Phase 4 | |
| Completed |
NCT04443920 -
Tranexamic Acid for Total Knee Arthroscopy
|
Phase 4 | |
| Withdrawn |
NCT04933253 -
Mediastinal Temperature and Post-operative Bleeding
|
N/A | |
| Recruiting |
NCT02938962 -
Intravenous vs. Topical Tranexamic Acid in Revision THA (VITALITY-X)
|
Phase 4 | |
| Recruiting |
NCT02130752 -
Ultrasonic Scalpel vs. Monopolar Electrocautery for D2 Distal Gastric Carcinoma Surgery
|
N/A | |
| Recruiting |
NCT05164809 -
Effect of Electrosurgery on Blood Loss and Intraoperative Transfusions in Musculoskeletal Tumor Surgery
|
||
| Not yet recruiting |
NCT04574128 -
Retransfusion or Not of Cardiotomy Blood
|
N/A | |
| Completed |
NCT02911831 -
IV Tranexamic Acid Prior to Hysterectomy
|
Early Phase 1 | |
| Completed |
NCT02740374 -
Evaluation of Thromboelastometry (ROTEM) During Spinal Surgery
|
N/A | |
| Enrolling by invitation |
NCT05474027 -
Reducing Hypotensive Anesthesia Use With TXA During Orthognathic Surgery
|
Phase 4 | |
| Completed |
NCT05391607 -
Comparison Between Hyperoncotic and Isooncotic Albumin to Support Blood Loss Replacement
|
Phase 4 | |
| Completed |
NCT03152461 -
Evaluation of the Clinical Performance of the Quantra System With the Quantra Surgical Cartridge
|
||
| Recruiting |
NCT02441751 -
Intraoperative Volume Management and QT Interval
|
||
| Completed |
NCT01053169 -
Observational Study of Prophylaxis and Treatment of Acute Perioperative Bleeding With Beriplex® P/N (Probe Study)
|
N/A |